Table 2. Number of Patients With TRAEsa.
| TRAE | Patients, No. (%) | |||
|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Any grade | |
| Total patients with TRAEs | 7 (58) | 1 (8) | 0 | 7 (58) |
| Fatigue | 4 | 1 | 0 | 5 |
| Injection site reaction | 2 | 0 | 0 | 1 |
| Night sweats | 1 | 0 | 0 | 1 |
| Myalgia | 0 | 1 | 0 | 1 |
| Patients with TRAEs in the 5-μg cohort (n = 6) | 3 (50) | 1 (17) | 0 | 4 (67) |
| Patients with TRAEs in the 10-μg cohort (n = 6) | 3 (50) | 0 | 0 | 3 (50) |
Abbreviation: TRAE, treatment-related adverse event.
a
Grading of adverse events was based on Common Terminology Criteria for Adverse Events, version 5.0.